Tectonic Therapeutic, Inc. SEC filings TECX
Tectonic Therapeutic, Inc. has 582 filings in SEC EDGAR's recent list, going back to Aug 3, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 10, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 23, 2026 | Apr 23, 2026 |
| S-8 POS | Filing | Mar 9, 2026 | — |
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 24, 2026 | Feb 23, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| EFFECT | Filing | Jul 15, 2025 | — |
| 424B3 | Prospectus | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 11, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2025 | — |
| EFFECT | Filing | Jul 8, 2025 | — |
| EFFECT | Filing | Jul 8, 2025 | — |
| POS AM | Filing | Jul 7, 2025 | — |
| POS AM | Filing | Jul 7, 2025 | — |
| S-3 | Shelf registration | Jul 7, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 6, 2025 |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 17, 2025 |
| 424B3 | Prospectus | May 8, 2025 | — |
| 424B3 | Prospectus | May 8, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 6, 2025 |
| EFFECT | Filing | Apr 3, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| POS AM | Filing | Mar 27, 2025 | — |
| S-1 | Registration statement | Mar 26, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| D | Filing | Feb 14, 2025 | — |
| 424B5 | Prospectus supplement | Feb 12, 2025 | — |
| 424B5 | Prospectus supplement | Feb 12, 2025 | — |
| 424B3 | Prospectus | Feb 12, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 30, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 19, 2024 | Sep 19, 2024 |
| S-8 POS | Filing | Aug 27, 2024 | — |
| S-8 | Employee stock plan registration | Aug 21, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 424B3 | Prospectus | Aug 14, 2024 | — |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 424B5 | Prospectus supplement | Jul 31, 2024 | — |
| EFFECT | Filing | Jul 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| 424B3 | Prospectus | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2024 | — |
| S-1 | Registration statement | Jul 19, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jul 5, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K/A |
Amended current report
Other events
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2024 | Jun 11, 2024 |
| 425 | Filing | Jun 4, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 4, 2024 | Jun 4, 2024 |
| 425 | Filing | Jun 3, 2024 | — |
| 425 | Filing | May 28, 2024 | — |
| 425 | Filing | May 21, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| SEC STAFF LETTER | Filing | May 7, 2024 | — |
| EFFECT | Filing | May 3, 2024 | — |
| 424B3 | Prospectus | May 3, 2024 | — |
| CORRESP | Letter to the SEC | May 2, 2024 | — |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| S-4/A | Filing | Apr 29, 2024 | — |
| SEC STAFF LETTER | Filing | Apr 24, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 15, 2024 | — |
| S-4/A | Filing | Apr 15, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2024 | — |
| 425 | Filing | Apr 4, 2024 | — |
| S-4/A | Filing | Mar 26, 2024 | — |
| CORRESP | Letter to the SEC | Mar 25, 2024 | — |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Mar 12, 2024 | — |
| S-4 | Registration for a merger or exchange | Feb 14, 2024 | — |
| 425 | Filing | Jan 30, 2024 | — |
| 425 | Filing | Jan 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 30, 2024 | Jan 30, 2024 |
| 425 | Filing | Jan 30, 2024 | — |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change, Regulation FD disclosure
|
Jan 30, 2024 | Jan 30, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| RW | Filing | Nov 3, 2023 | — |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jul 12, 2023 | Jul 6, 2023 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Jun 14, 2023 | May 19, 2023 |
| 8-K |
Current report
Other events
|
Jun 13, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
|
Jun 12, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Regulation FD disclosure
|
May 22, 2023 | May 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | May 5, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 1, 2023 | Apr 28, 2023 |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Other events
|
Feb 27, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2022 | Dec 7, 2022 |
| S-3 | Shelf registration | Nov 8, 2022 | — |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Listing notice
|
Oct 7, 2022 | Oct 4, 2022 |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 29, 2022 | Jun 27, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2022 | May 24, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2022 | May 18, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2022 | May 17, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 8, 2022 |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 10-K | Annual report | Mar 17, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 9, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Jan 7, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Other events
|
Jan 4, 2022 | Jan 4, 2022 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 19, 2021 | Oct 19, 2021 |
| 8-K |
Current report
Other events
|
Aug 9, 2021 | Aug 9, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Other events
|
Jun 17, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2021 | Jun 10, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Other events
|
May 3, 2021 | May 3, 2021 |
| DEFA14A | Additional proxy material | Apr 22, 2021 | — |
| DEF 14A | Proxy statement | Apr 22, 2021 | Jun 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2021 | Mar 23, 2021 |
| S-8 | Employee stock plan registration | Mar 18, 2021 | — |
| 10-K | Annual report | Mar 18, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 8, 2021 | Feb 8, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 20, 2020 | Nov 19, 2020 |
| 424B5 | Prospectus supplement | Nov 20, 2020 | — |
| 424B5 | Prospectus supplement | Nov 19, 2020 | — |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 17, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 21, 2020 | Oct 19, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2020 | Oct 6, 2020 |
| 8-K |
Current report
Other events
|
Oct 5, 2020 | Oct 5, 2020 |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Other events
|
Jul 6, 2020 | Jul 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 13, 2020 | May 13, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEF 14A | Proxy statement | Apr 22, 2020 | Jun 4, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2020 | Apr 3, 2020 |
| 8-K |
Current report
Other events
|
Mar 30, 2020 | Mar 30, 2020 |
| S-8 | Employee stock plan registration | Mar 16, 2020 | — |
| 10-K | Annual report | Mar 16, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Feb 13, 2020 | Feb 12, 2020 |
| 424B5 | Prospectus supplement | Feb 13, 2020 | — |
| 424B5 | Prospectus supplement | Feb 12, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1681087
- Former names
- AvroBio, Inc. (until Jun 18, 2024); AVROBIO, Inc. (until Jun 18, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.